Adnexal ยท DigitalICD-10 C44

Aggressive digital papillary adenocarcinoma

ADPA; digital papillary carcinoma; aggressive papillary adenoma (older term โ€” now obsolete; all are now considered carcinomas)

Aggressive digital papillary adenocarcinoma is a rare sweat-gland adenocarcinoma virtually confined to the volar surfaces of the distal fingers, toes, palms and soles of middle-aged and elderly adults. Despite a deceptively benign clinical appearance โ€” typically a slowly enlarging, painless, skin-coloured nodule โ€” it has marked metastatic potential, with up to 40% of cases recurring locally and 15โ€“40% developing pulmonary metastases (the lung is by far the commonest distant site). Wide local excision or ray/distal-phalanx amputation with histological clearance plus sentinel-lymph-node biopsy and surveillance imaging of the chest are the cornerstones of management. The 2000 series by Duke and colleagues abolished the previous distinction between "adenoma" and "adenocarcinoma" โ€” all such tumours are now considered carcinomas because of their metastatic risk; Suchak and colleagues (2012) subsequently questioned the prefix "aggressive".

CurrentLast reviewed 26 April 2026

Clinical features

  • Slowly enlarging, painless, skin-coloured to red dermal/subcutaneous nodule.
  • Almost always on the volar (palmar/plantar) surface of a digit (~80%) โ€” most often the finger, then thumb, toe and palm.
  • Median age 50; M:F ~2:1.
  • Often misdiagnosed as ganglion, epidermoid cyst, foreign-body granuloma or fibroma โ€” diagnostic delay common.
  • May ulcerate or fix to deeper structures (tendon, joint, bone) when long-standing.

Histology

  • Multinodular dermal proliferation of glandular and tubulo-papillary structures with intraluminal papillary projections.
  • Cystic spaces with eosinophilic secretion.
  • Variable cytological atypia, mitoses and necrosis.
  • Lymphovascular invasion is a particularly adverse feature.
  • Immunohistochemistry: CK7+, EMA+, CEA+; S100 variable.
  • Differential: metastatic adenocarcinoma (lung, breast, GI) โ€” clinical history and imaging essential.

Management

  • Wide local excision with โ‰ฅ1โ€“2 cm margins is rarely feasible on a digit; ray amputation or distal phalanx amputation is the most common definitive procedure.
  • Sentinel lymph node biopsy strongly recommended given metastatic risk.
  • Imaging โ€” CT chest at diagnosis and at 6-monthly intervals for at least 2 years; MRI of the digit to assess deep extension.
  • Adjuvant radiotherapy considered for incomplete margins or extensive disease where amputation declined.
  • Pulmonary metastasectomy can be curative for oligometastatic disease โ€” refer to thoracic MDT.
  • Systemic therapy for widely metastatic disease โ€” limited evidence; carboplatin/paclitaxel and immunotherapy reported.

Prognosis

Local recurrence 30โ€“50% with conservative excision; ray amputation reduces this to <10%. Pulmonary metastasis 15โ€“40% โ€” most common cause of disease-specific death. Long-term surveillance for at least 10 years is essential, including 6โ€“12-monthly chest CT for the first 2 years.

References

  1. Duke WH et al. Aggressive digital papillary adenocarcinoma โ€” review. Am J Surg Pathol; 2000.
  2. Suchak R et al. Cutaneous digital papillary adenocarcinoma โ€” clinicopathologic study. Am J Surg Pathol; 2012.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.